These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17430093)

  • 21. LRP1 expression in microglia is protective during CNS autoimmunity.
    Chuang TY; Guo Y; Seki SM; Rosen AM; Johanson DM; Mandell JW; Lucchinetti CF; Gaultier A
    Acta Neuropathol Commun; 2016 Jul; 4(1):68. PubMed ID: 27400748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis.
    Touil H; Kobert A; Lebeurrier N; Rieger A; Saikali P; Lambert C; Fawaz L; Moore CS; Prat A; Gommerman J; Antel JP; Itoyama Y; Nakashima I; Bar-Or A;
    J Neuroinflammation; 2018 Apr; 15(1):114. PubMed ID: 29673365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myelin reactive T cells in the autoimmune pathogenesis of multiple sclerosis.
    Stinissen P; Medaer R; Raus J
    Mult Scler; 1998 Jun; 4(3):203-11. PubMed ID: 9762675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
    Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
    Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
    Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
    Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity.
    Moalem G; Gdalyahu A; Shani Y; Otten U; Lazarovici P; Cohen IR; Schwartz M
    J Autoimmun; 2000 Nov; 15(3):331-45. PubMed ID: 11040074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple sclerosis: a pivotal role for the T cell in lesion development.
    Raine CS
    Neuropathol Appl Neurobiol; 1991 Aug; 17(4):265-74. PubMed ID: 1944803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunology for understanding the pathogenesis of multiple sclerosis].
    Matsui M
    Rinsho Shinkeigaku; 2013; 53(11):898-901. PubMed ID: 24291827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions.
    Windhagen A; Newcombe J; Dangond F; Strand C; Woodroofe MN; Cuzner ML; Hafler DA
    J Exp Med; 1995 Dec; 182(6):1985-96. PubMed ID: 7500044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
    Zozulya AL; Wiendl H
    Hum Immunol; 2008 Nov; 69(11):797-804. PubMed ID: 18723060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune regulation of multiple sclerosis.
    Hartung HP; Aktas O; Menge T; Kieseier BC
    Handb Clin Neurol; 2014; 122():3-14. PubMed ID: 24507511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of neurotrophins in multiple sclerosis-pathological and clinical implications.
    Kalinowska-Lyszczarz A; Losy J
    Int J Mol Sci; 2012 Oct; 13(10):13713-25. PubMed ID: 23202976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune-mediated oligodendrocyte injury in multiple sclerosis: molecular mechanisms and therapeutic interventions.
    Buntinx M; Stinissen P; Steels P; Ameloot M; Raus J
    Crit Rev Immunol; 2002; 22(5-6):391-424. PubMed ID: 12803318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knocking at the brain's door: intravital two-photon imaging of autoreactive T cell interactions with CNS structures.
    Kawakami N; Flügel A
    Semin Immunopathol; 2010 Sep; 32(3):275-87. PubMed ID: 20623286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EBV in MS: guilty by association?
    Lünemann JD; Münz C
    Trends Immunol; 2009 Jun; 30(6):243-8. PubMed ID: 19428300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple sclerosis as a by-product of the failure to sustain protective autoimmunity: a paradigm shift.
    Schwartz M; Kipnis J
    Neuroscientist; 2002 Oct; 8(5):405-13. PubMed ID: 12374425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of autoimmune CNS inflammation by astrocytes.
    Rothhammer V; Quintana FJ
    Semin Immunopathol; 2015 Nov; 37(6):625-38. PubMed ID: 26223505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological basis for the development of tissue inflammation and organ-specific autoimmunity in animal models of multiple sclerosis.
    Korn T; Mitsdoerffer M; Kuchroo VK
    Results Probl Cell Differ; 2010; 51():43-74. PubMed ID: 19513635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunopathogenesis of multiple sclerosis.
    Giovannoni G
    Baillieres Clin Neurol; 1997 Oct; 6(3):387-407. PubMed ID: 10101580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.